From: Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine
Variable | Risk Ratio | Two-sided p-value |
---|---|---|
(95% CI) | (NS > 0.25) | |
Vaccination with 80ug | 2.01 (1.26, 3.20) | 0.0035 |
AMA1-C1 | ||
Age at time of anaemia event* | 0.45 (0.29, 0.70) | 0.0004 |
Baseline Hg > = 10 g/dL | 0.78 (0.52, 1.17) | NS |
Baseline Hg < 10 g/dL | 4.26 (2.72, 6.69) | < 0.0001 |
Male Sex | 0.74 (0.46, 1.17) | NS |
HbS | 0.83 (0.42, 1.61) | NS |
HbC | 0.96 (0.43, 2.15) | NS |
G6PD deficiency | 2.27 (0.85, 6.04) | NS |
α-thalassaemia heterozygote | 0.71 (0.41, 1.23) | NS |
α-thalassaemia homozygote | 0.41 (0.12, 1.45) | NS |